PHARMACIE NANCY PEERS

Mouscron ·KBO/BCE: BE 0802.546.425

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
30-06-2025	31-01-2026	30-01-2026	1 d early	2026-00021757
30-06-2024	31-01-2025	03-02-2025	3 d late	2025-00025415

Metric	This company	Sector median	Position in the sector
Solvency	39.4%	23.5%	better than 64% of 1432 sector peers
Net result	€73k	€7k	better than 91% of 1429 sector peers
Equity	€260k	€25k	better than 95% of 1434 sector peers
Gross operating margin	€234k	€34k	better than 94% of 1426 sector peers
Staff costs	€103k	€42k	higher than 80% of 605 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€660k
Fixed assets	21/28	€58k
Tangible fixed assets	22/27	€58k
Financial fixed assets	28	€74
Current assets	29/58	€601k
Stocks & contracts in progress	3	€148k
Amounts receivable within one year	40/41	€86k
Investments	50/53	€50k
Cash & bank	54/58	€311k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€660k
Equity	10/15	€260k
Contributions / capital	10/11	€2k
Reserves	13	€258k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€400k
Amounts payable after one year	17	€131k
Amounts payable within one year	42/48	€265k
Trade debts payable within one year	44	€63k
Income statement
Gross operating margin	9900	€234k
Operating result	9901	€111k
Financial income	75	€4k
Financial charges	65	€12k
Result before taxes	9903	€102k
Income taxes	67/77	€29k
Net result for the period	9904	€73k
Result to be appropriated	9905	€73k

Summary